Recent Advances in In Vitro and In Vivo Studies of Antioxidant, ACE-Inhibitory and Anti-Inflammatory Peptides from Legume Protein Hydrolysates.
Deia TawalbehMuhammad H Al-U'dattWan Amir Nizam Wan AhmadFisal AhmadNorizah Mhd SarbonPublished in: Molecules (Basel, Switzerland) (2023)
Consumption of legumes has been shown to enhance health and lower the risk of cardiovascular disease and specific types of cancer. ACE inhibitors, antioxidants, and synthetic anti-inflammatories are widely used today; however, they have several undesirable side effects. Thus, researchers have focused on finding ACE inhibitors, antioxidant, and anti-inflammatory peptides from natural sources, such as legumes. Recently, in vitro and in vivo research has shown the bioactive peptides generated from legume protein hydrolysates, such as antioxidant, anti-hypertensive, anticancer, anti-proliferative, anti-inflammatory, etc., in the context of different disease mitigation. Therefore, this review aims to describe the recent advances in in vitro and in vivo studies of antioxidant, anti-hypertensive and anti-inflammatory peptides isolated from legume-derived protein hydrolysates. The results indicated that antioxidant legumes peptides are characterized by short-chain sequence amino acids and possess anti-hypertensive properties by reducing systolic blood pressure (SBP) in spontaneously hypertensive rats (SHR).
Keyphrases
- anti inflammatory
- amino acid
- blood pressure
- cardiovascular disease
- oxidative stress
- healthcare
- hypertensive patients
- public health
- angiotensin ii
- mental health
- angiotensin converting enzyme
- type diabetes
- squamous cell carcinoma
- adipose tissue
- cardiovascular events
- metabolic syndrome
- climate change
- atrial fibrillation
- papillary thyroid